Skip to main content
Erschienen in: Quality of Life Research 12/2017

01.08.2017

Do male esophageal cancer patients have impaired sexual function after esophagectomy? A self-reported outcomes study

verfasst von: Xun Cao, Jiu-Di Zhong, Tian-Zhen Yang, Yu-Chuan Jiang, Zhe-Sheng Wen

Erschienen in: Quality of Life Research | Ausgabe 12/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Sexual function is a significant part of patients' quality of life, which is another important aspect of cancer. This study assessed and compared the sexual function of male esophageal cancer patients to that of age-matched normal controls through postoperative follow-up surveys.

Methods

The study included 105 male esophageal cancer patients aged 38–81 years who underwent a curative-intent esophagectomy between April 2012 and May 2014. This observational study included sociodemographic and clinicopathological characteristics and responses to sexual function questionnaires International Index of Erectile Function (IIEF) at 6 and 12 months after surgery. An age-matched normal control group was recruited. Non-parametric tests were used when appropriate.

Results

The median patient age was 59 years. The factors significantly associated with sexual dysfunction on the 6-month survey included older age, and postoperative complications. At 12 months after surgery, older age was significantly associated with poorer sexual function. The sexual function scores significantly increased from 6 to 12 months after surgery (P < 0.05); there was no difference in the patients’ 12-month sexual function scores and those of the normal controls (P > 0.05). Notably, compared to older patients (age ≥60 years), the younger (age <60 years) patients reported a significantly better sexual function scores (P < 0.05).

Conclusions

Age, and postoperative complications were the factors significantly associated with sexual function. Impaired sexual function after primary treatment can be recovered in male esophageal cancer patients; younger patients may regain sexual function better than their older counterparts.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet-Tieulent, J., & Jemal, A. (2015). Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians, 65(2), 87–108. doi:10.3322/caac.21262. Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet-Tieulent, J., & Jemal, A. (2015). Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians, 65(2), 87–108. doi:10.​3322/​caac.​21262.
2.
Zurück zum Zitat Ke, L. (2002). Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970–90. International Journal of Cancer. Journal international du cancer, 102(3), 271–274. doi:10.1002/ijc.10706.CrossRefPubMed Ke, L. (2002). Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970–90. International Journal of Cancer. Journal international du cancer, 102(3), 271–274. doi:10.​1002/​ijc.​10706.CrossRefPubMed
3.
Zurück zum Zitat Tepper, J., Krasna, M. J., Niedzwiecki, D., Hollis, D., Reed, C. E., Goldberg, R., et al. (2008). Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 26(7), 1086–1092. doi:10.1200/JCO.2007.12.9593.CrossRef Tepper, J., Krasna, M. J., Niedzwiecki, D., Hollis, D., Reed, C. E., Goldberg, R., et al. (2008). Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 26(7), 1086–1092. doi:10.​1200/​JCO.​2007.​12.​9593.CrossRef
4.
Zurück zum Zitat Ando, N., Iizuka, T., Ide, H., Ishida, K., Shinoda, M., Nishimaki, T., et al. (2003). Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan Clinical Oncology Group Study–JCOG9204. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 21(24), 4592–4596. doi:10.1200/JCO.2003.12.095.CrossRef Ando, N., Iizuka, T., Ide, H., Ishida, K., Shinoda, M., Nishimaki, T., et al. (2003). Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan Clinical Oncology Group Study–JCOG9204. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 21(24), 4592–4596. doi:10.​1200/​JCO.​2003.​12.​095.CrossRef
5.
Zurück zum Zitat Ando, N., Ozawa, S., Kitagawa, Y., Shinozawa, Y., & Kitajima, M. (2000). Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Annals of Surgery, 232(2), 225–232.CrossRefPubMedPubMedCentral Ando, N., Ozawa, S., Kitagawa, Y., Shinozawa, Y., & Kitajima, M. (2000). Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Annals of Surgery, 232(2), 225–232.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Greenfield, D. M., Walters, S. J., Coleman, R. E., Hancock, B. W., Snowden, J. A., Shalet, S. M., et al. (2010). Quality of life, self-esteem, fatigue, and sexual function in young men after cancer: a controlled cross-sectional study. Cancer, 116(6), 1592–1601. doi:10.1002/cncr.24898.CrossRefPubMed Greenfield, D. M., Walters, S. J., Coleman, R. E., Hancock, B. W., Snowden, J. A., Shalet, S. M., et al. (2010). Quality of life, self-esteem, fatigue, and sexual function in young men after cancer: a controlled cross-sectional study. Cancer, 116(6), 1592–1601. doi:10.​1002/​cncr.​24898.CrossRefPubMed
8.
Zurück zum Zitat Stanford, J. L., Feng, Z., Hamilton, A. S., Gilliland, F. D., Stephenson, R. A., Eley, J. W., et al. (2000). Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA, 283(3), 354–360.CrossRefPubMed Stanford, J. L., Feng, Z., Hamilton, A. S., Gilliland, F. D., Stephenson, R. A., Eley, J. W., et al. (2000). Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA, 283(3), 354–360.CrossRefPubMed
9.
10.
11.
Zurück zum Zitat Malinovszky, K. M., Gould, A., Foster, E., Cameron, D., Humphreys, A., Crown, J., et al. (2006). Quality of life and sexual function after high-dose or conventional chemotherapy for high-risk breast cancer. British Journal of Cancer, 95(12), 1626–1631. doi:10.1038/sj.bjc.6603454.CrossRefPubMedPubMedCentral Malinovszky, K. M., Gould, A., Foster, E., Cameron, D., Humphreys, A., Crown, J., et al. (2006). Quality of life and sexual function after high-dose or conventional chemotherapy for high-risk breast cancer. British Journal of Cancer, 95(12), 1626–1631. doi:10.​1038/​sj.​bjc.​6603454.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Stillman, R. J., Schinfeld, J. S., Schiff, I., Gelber, R. D., Greenberger, J., Larson, M., et al. (1981). Ovarian failure in long-term survivors of childhood malignancy. American Journal of Obstetrics and Gynecology, 139(1), 62–66.CrossRefPubMed Stillman, R. J., Schinfeld, J. S., Schiff, I., Gelber, R. D., Greenberger, J., Larson, M., et al. (1981). Ovarian failure in long-term survivors of childhood malignancy. American Journal of Obstetrics and Gynecology, 139(1), 62–66.CrossRefPubMed
13.
Zurück zum Zitat Chapman, R. M., Sutcliffe, S. B., & Malpas, J. S. (1979). Cytotoxic-induced ovarian failure in Hodgkin’s disease. II. Effects on sexual function. Jama, 242(17), 1882–1884.CrossRefPubMed Chapman, R. M., Sutcliffe, S. B., & Malpas, J. S. (1979). Cytotoxic-induced ovarian failure in Hodgkin’s disease. II. Effects on sexual function. Jama, 242(17), 1882–1884.CrossRefPubMed
16.
Zurück zum Zitat Donovan, K. A., Thompson, L. M., & Hoffe, S. E. (2010). Sexual function in colorectal cancer survivors. Cancer Control: Journal of the Moffitt Cancer Center, 17(1), 44–51.CrossRef Donovan, K. A., Thompson, L. M., & Hoffe, S. E. (2010). Sexual function in colorectal cancer survivors. Cancer Control: Journal of the Moffitt Cancer Center, 17(1), 44–51.CrossRef
17.
Zurück zum Zitat Traa, M. J., De Vries, J., Roukema, J. A., & Den Oudsten, B. L. (2012). Sexual (dys)function and the quality of sexual life in patients with colorectal cancer: a systematic review. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 23(1), 19–27. doi:10.1093/annonc/mdr133.CrossRef Traa, M. J., De Vries, J., Roukema, J. A., & Den Oudsten, B. L. (2012). Sexual (dys)function and the quality of sexual life in patients with colorectal cancer: a systematic review. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 23(1), 19–27. doi:10.​1093/​annonc/​mdr133.CrossRef
19.
Zurück zum Zitat Kiserud, C. E., Schover, L. R., Dahl, A. A., Fossa, A., Bjoro, T., Loge, J. H., et al. (2009). Do male lymphoma survivors have impaired sexual function? Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 27(35), 6019–6026. doi:10.1200/JCO.2009.23.2280.CrossRef Kiserud, C. E., Schover, L. R., Dahl, A. A., Fossa, A., Bjoro, T., Loge, J. H., et al. (2009). Do male lymphoma survivors have impaired sexual function? Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 27(35), 6019–6026. doi:10.​1200/​JCO.​2009.​23.​2280.CrossRef
20.
Zurück zum Zitat Rosen, R. C., Riley, A., Wagner, G., Osterloh, I. H., Kirkpatrick, J., & Mishra, A. (1997). The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology, 49(6), 822–830.CrossRefPubMed Rosen, R. C., Riley, A., Wagner, G., Osterloh, I. H., Kirkpatrick, J., & Mishra, A. (1997). The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology, 49(6), 822–830.CrossRefPubMed
21.
Zurück zum Zitat Jeffery, D. D., Tzeng, J. P., Keefe, F. J., Porter, L. S., Hahn, E. A., Flynn, K. E., et al. (2009). Initial report of the cancer Patient-Reported Outcomes Measurement Information System (PROMIS) sexual function committee: review of sexual function measures and domains used in oncology. Cancer, 115(6), 1142–1153. doi:10.1002/cncr.24134.CrossRefPubMedPubMedCentral Jeffery, D. D., Tzeng, J. P., Keefe, F. J., Porter, L. S., Hahn, E. A., Flynn, K. E., et al. (2009). Initial report of the cancer Patient-Reported Outcomes Measurement Information System (PROMIS) sexual function committee: review of sexual function measures and domains used in oncology. Cancer, 115(6), 1142–1153. doi:10.​1002/​cncr.​24134.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Cull, A. M. (1992). The assessment of sexual function in cancer patients. European Journal of Cancer, 28A(10), 1680–1686.CrossRefPubMed Cull, A. M. (1992). The assessment of sexual function in cancer patients. European Journal of Cancer, 28A(10), 1680–1686.CrossRefPubMed
24.
25.
Zurück zum Zitat Lee, S. J., Schover, L. R., Partridge, A. H., Patrizio, P., Wallace, W. H., Hagerty, K., et al. (2006). American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 24(18), 2917–2931. doi:10.1200/JCO.2006.06.5888.CrossRef Lee, S. J., Schover, L. R., Partridge, A. H., Patrizio, P., Wallace, W. H., Hagerty, K., et al. (2006). American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 24(18), 2917–2931. doi:10.​1200/​JCO.​2006.​06.​5888.CrossRef
26.
Zurück zum Zitat Howell, S. J., Radford, J. A., Ryder, W. D., & Shalet, S. M. (1999). Testicular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 17(5), 1493–1498.CrossRef Howell, S. J., Radford, J. A., Ryder, W. D., & Shalet, S. M. (1999). Testicular function after cytotoxic chemotherapy: evidence of Leydig cell insufficiency. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 17(5), 1493–1498.CrossRef
27.
28.
Zurück zum Zitat (1992) Drugs that cause sexual dysfunction: an update. Med Letter Drugs Therapeutics 34(876):73–78. (1992) Drugs that cause sexual dysfunction: an update. Med Letter Drugs Therapeutics 34(876):73–78.
29.
Zurück zum Zitat Andersen, B. L. (1985). Sexual functioning morbidity among cancer survivors. Current status and future research directions. Cancer, 55(8), 1835–1842.CrossRefPubMedPubMedCentral Andersen, B. L. (1985). Sexual functioning morbidity among cancer survivors. Current status and future research directions. Cancer, 55(8), 1835–1842.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Howell, S. J., & Shalet, S. M. (2001). Testicular function following chemotherapy. Hum Hum update, 7(4), 363–369.CrossRef Howell, S. J., & Shalet, S. M. (2001). Testicular function following chemotherapy. Hum Hum update, 7(4), 363–369.CrossRef
31.
Zurück zum Zitat White, C. A. (2000). Body image dimensions and cancer: a heuristic cognitive behavioural model. Psycho-oncology, 9(3), 183–192.CrossRefPubMed White, C. A. (2000). Body image dimensions and cancer: a heuristic cognitive behavioural model. Psycho-oncology, 9(3), 183–192.CrossRefPubMed
32.
Zurück zum Zitat Woodgate, R. L. (2005). A different way of being: adolescents’ experiences with cancer. Cancer Nursing, 28(1), 8–15.CrossRefPubMed Woodgate, R. L. (2005). A different way of being: adolescents’ experiences with cancer. Cancer Nursing, 28(1), 8–15.CrossRefPubMed
33.
Zurück zum Zitat Glasgow, M., Halfin, V., & Althausen, A. F. (1987). Sexual response and cancer. CA: A Cancer Journal for Clinicians, 37(6), 322–333. Glasgow, M., Halfin, V., & Althausen, A. F. (1987). Sexual response and cancer. CA: A Cancer Journal for Clinicians, 37(6), 322–333.
34.
Zurück zum Zitat Ropponen, P., Siimes, M. A., Rautonen, J., & Aalberg, V. (1992). Psychosexual problems in male childhood malignancy survivors. Acta Psychiatrica Scandinavica, 85(2), 143–146.CrossRefPubMed Ropponen, P., Siimes, M. A., Rautonen, J., & Aalberg, V. (1992). Psychosexual problems in male childhood malignancy survivors. Acta Psychiatrica Scandinavica, 85(2), 143–146.CrossRefPubMed
Metadaten
Titel
Do male esophageal cancer patients have impaired sexual function after esophagectomy? A self-reported outcomes study
verfasst von
Xun Cao
Jiu-Di Zhong
Tian-Zhen Yang
Yu-Chuan Jiang
Zhe-Sheng Wen
Publikationsdatum
01.08.2017
Verlag
Springer International Publishing
Erschienen in
Quality of Life Research / Ausgabe 12/2017
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-017-1677-3

Weitere Artikel der Ausgabe 12/2017

Quality of Life Research 12/2017 Zur Ausgabe